EUGIA US LLC — Acyclovir Importer Profile
Pharmaceutical Importer · #10 buyer for Acyclovir · $1.9M import value · 43 shipments · UNITED STATES · DGFT Verified
EUGIA US LLC is the #10 importer of Acyclovir from India with $1.9M in import value and 43 verified shipments. EUGIA US LLC holds a 1.1% market share in Acyclovir imports based in UNITED STATES. The company sources from 1 verified supplier across 34 formulations shipped to 2 countries. Overall, EUGIA US LLC imports 27 pharmaceutical products worth $66.2M across 13 therapeutic categories.
EUGIA US LLC — Acyclovir Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Acyclovir to EUGIA US LLC?
Verified from 43 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| EUGIA PHARMA SPECIALITIES LIMITED | $1.9M | 43 | 100.0% |
EUGIA US LLC sources Acyclovir from 1 verified Indian supplier based on 43 customs records. The primary supplier is EUGIA PHARMA SPECIALITIES LIMITED accounting for 100.0% of imports.
How Does EUGIA US LLC Compare to Nearest Acyclovir Importers?
Buyers ranked immediately above and below #10 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | SIVEM PHARMACEUTICALS | UNITED STATES | $1.6M | 31 | $50.0K |
| 8 | CAMBER PHARMACEUTICALS INC | UNITED STATES | $1.4M | 28 | $50.0K |
| 10 | EUGIA US LLC ★ | UNITED STATES | $1.4M | 27 | $50.0K |
| 13 | JAMP PHARMA CORPORATION | CANADA | $1.3M | 37 | $35.6K |
| 1 | MYLAN PHARMACEUTICALS INC, | UNITED STATES | $1.1M | 23 | $50.0K |
EUGIA US LLC ranks #10 among 879 Acyclovir importers from India. Average shipment value of $50.0K compared to the market average of $21.4K. The closest competitors by value are SIVEM PHARMACEUTICALS and CAMBER PHARMACEUTICALS INC.
Where Does EUGIA US LLC Import Acyclovir To?
Destination countries from 43 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.7M | 39 | 92.1% |
| UNITED STATES OF AMERICA | $148.9K | 4 | 7.9% |
EUGIA US LLC imports Acyclovir to 2 countries. The primary destination is UNITED STATES receiving 92.1% of shipments worth $1.7M.
What Acyclovir Formulations Does EUGIA US LLC Import?
| Formulation | Value | Shipments |
|---|---|---|
| ACYCLOVIR SODIUM INJECTION 500MG/10 ML [50 MG/ML] (9084X10'S) | $131.9K | 3 |
| ACYCLOVIR SODIUM INJECTION 500 MG/ 10 ML[50 MG/ ML] - US MARKET (10 SPACK) (QTY: 9104 PACKS) | $126.3K | 3 |
| ACYCLOVIR SODIUM INJECTION 1000 MG/20 ML(50MG/ML) (4800X10'S) | $123.3K | 3 |
| ACYCLOVIR SODIUM INJECTION 500 MG/ 10 ML[50 MG/ ML]- US MARKET (10 S PACK) (QTY: 8952 PACKS) | $120.9K | 3 |
| ACYCLOVIR SODIUM INJECTION 1000 MG/20 ML | $77.6K | 2 |
| ACYCLOVIR SODIUM INJECTION 500MG 10 ML 50 MG ML 6288X10 S | $50.0K | 1 |
| ACYCLOVIR SODIUM INJECTION 500MG 10 ML 50 MG ML 6210X10 S | $50.0K | 1 |
| ACYCLOVIR SODIUM INJECTION 1000 MG/20 ML50 MG/ML - US MARKET 10 S PACK QTY: 8080 PACKS | $50.0K | 1 |
| ACYCLOVIR SODIUM INJECTION 1000 MG/20 ML50 MG/ML 4420X10'S | $50.0K | 1 |
| ACYCLOVIR SODIUM INJECTION 500 MG/ 10 ML[50 MG/ ML] - US MARKET (10 S PACK) (QTY: 6425 PACKS) | $50.0K | 1 |
EUGIA US LLC imports 34 distinct Acyclovir formulations from India. The top formulation is ACYCLOVIR SODIUM INJECTION 500MG/10 ML [50 MG/ML] (9084X10'S with 3 shipments worth $131.9K.
Regulatory Requirements: Importing Acyclovir into United States
What EUGIA US LLC and other importers must comply with to import Acyclovir from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Acyclovir
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Acyclovir from India and How Much Does EUGIA US LLC Import?
India exported $18.8M worth of Acyclovir through 5,956 shipments from 358 suppliers to 152 countries, serving 879 buyers globally. EUGIA US LLC imports $1.9M of this total, accounting for 1.1% of India's Acyclovir exports with 43 shipments from UNITED STATES. This is verified from 43 customs shipment records covering 34 distinct formulations.
What Is the Average Order Value for EUGIA US LLC's Acyclovir Imports?
EUGIA US LLC's average Acyclovir order value is $43.6K per consignment, based on 43 shipments totaling $1.9M. EUGIA US LLC is based in UNITED STATES and ranks #10 among all Acyclovir importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Acyclovir to EUGIA US LLC?
EUGIA US LLC sources Acyclovir from 1 verified Indian supplier: EUGIA PHARMA SPECIALITIES LIMITED ($1.9M, 100.0%). This is based on 43 customs records.
How Does EUGIA US LLC Compare to Other Acyclovir Importers?
EUGIA US LLC ranks #10 among 879 Acyclovir importers from India with a 1.1% market share. The top 3 importers are EVERSANA LIFE SCIENCE SERVICES ($4.6M), XXMBEXXPHAXXACEXXICAXX IXX ($3.2M), SIVEM PHARMACEUTICALS ($1.6M). EUGIA US LLC processed 43 shipments from UNITED STATES.
About EUGIA US LLC
EUGIA US LLC imports 27 products worth $66.2M. Beyond Acyclovir, top products include Ertapenem, Pantoprazole, Meropenem, Piperacillin, Sodium. View the complete EUGIA US LLC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Acyclovir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Acyclovir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: EUGIA US LLC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as EUGIA US LLC's capped import value divided by total capped export value for Acyclovir across all Indian exporters.
- 5.Verified Records: This page is backed by 43 individual customs records matching EUGIA US LLC importing Acyclovir, covering 34 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 152+ countries, 879+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Acyclovir Import Data for EUGIA US LLC
Access order-level details, pricing data, supplier connections, and competitive analysis for EUGIA US LLC's Acyclovir imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
EUGIA US LLC
Full Company Profile →
27 products · $66.2M total trade · 13 categories
EUGIA US LLC × Acyclovir
Verified from customs records
Company Overview
Top Products by EUGIA US LLC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for EUGIA US LLC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Acyclovir. For current order-level data, contact TransData Nexus.